Sponsor:
HiFiBiO Therapeutics
Code:
NCT05789069
Conditions
Renal Cell Carcinoma
Melanoma
Non Small Cell Lung Cancer
Gastric Cancer
Colorectal Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
HFB200603
Tislelizumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-04-15. This information was provided to ClinicalTrials.gov by HiFiBiO Therapeutics on 2025-06-15.